HTI

www.companiesandmarkets.com: Halozyme Therapeutics Inc - Corporate and Strategic Assessment Report - 10/07 - 11:26 AM ET

CRI Canada Announces ProLender 8.0 - 07/17 - 12:06 AM ET

Halozyme says Chemophases meets primary endpoint in Phase I/IIa trial - 06/30 - 04:53 PM ET

Halozyme says Chemophase meets primary endpoint in Phase I/IIa trial - 06/30 - 04:53 PM ET

Form 4 Oracle: Boston, MA -- Form4Oracle: Insider Trading Report: Halozyme Therapeutics Inc (HALO) - 06/24 - 06:22 AM ET

Form 4 Oracle: Boston, MA -- Form4Oracle: Insider Trading Report: Halozyme Therapeutics Inc (HALO) - 03/21 - 06:05 AM ET

Halozyme Therapeutics 4Q net loss wider than Street estimates - 03/13 - 07:40 PM ET

Halozyme Therapeutics 3Q net loss widens as revenue rises - 11/08 - 06:54 PM ET

CRI Canada and Selient Announce Joint Agreement - 10/19 - 02:14 PM ET

<< Back to Stock Index